Latest news
CytomX Therapeutics secures $37M from Regeneron amid Q2 revenue miss - scanx.tradescanx.trade · Fri, 07 Aug 2026 02:21:26 GMTCytomX Therapeutics Q2 Earnings Call Highlights - TradingViewTradingView · Fri, 07 Aug 2026 01:03:00 GMTCytomX Therapeutics, Inc. (CTMX) awards 450,000 options and 100,000 RSUs to CLO - stocktitan.netstocktitan.net · Wed, 05 Aug 2026 23:33:53 GMTCytomX Therapeutics, Inc. (CTMX) Chief Legal Officer files Form 3 insider report - stocktitan.netstocktitan.net · Wed, 05 Aug 2026 23:32:38 GMTCytomX Therapeutics Chief Legal Officer Alejandra Carvajal files initial beneficial ownership statement - BitgetBitget · Wed, 05 Aug 2026 15:32:45 GMTCytomX Therapeutics names Alejandra Carvajal chief legal officer - BitgetBitget · Mon, 03 Aug 2026 07:00:00 GMTCytomX Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026 - The Manila TimesThe Manila Times · Thu, 30 Jul 2026 12:23:33 GMTCytomX Therapeutics Announces Date for Second Quarter 2026 Financial Results Conference Call - Quiver QuantitativeQuiver Quantitative · Thu, 30 Jul 2026 12:15:00 GMT